Literature DB >> 30639171

Frailty as a Predictor of All-Cause Mortality Among Older Nursing Home Residents: A Systematic Review and Meta-analysis.

XiaoMing Zhang1, QingLi Dou2, WenWu Zhang2, CongHua Wang2, XiaoHua Xie3, YunZhi Yang4, YingChun Zeng5.   

Abstract

OBJECTIVES: We performed a meta-analysis based on prospective cohort studies to synthesize the pooled risk effect and to determine whether frailty is a predictor of all-cause mortality.
DESIGN: Systematic review and meta-analysis.
SETTING: PubMed, EMBASE, and the Cochrane Library were systematically searched in October 2018. A random effects model was applied to combine the results according to the heterogeneity of the included studies. PARTICIPANTS: Older nursing home residents. MEASUREMENTS: Mortality risk due to frailty.
RESULTS: Fourteen studies (9076 participants) were included in this meta-analysis. Pooled results demonstrated that nursing home residents with frailty were at an increased risk of mortality [pooled hazards ratio (HR) = 1.88, 95% confidence interval (CI) = 1.57, 2.25, I2 = 47.8%, P < .001] compared to those without frailty. Results of subgroup analyses showed that frailty was significantly associated with the risk of mortality among older nursing home residents when using FRAIL-NH (pooled HR = 2.10, 95% CI = 1.60-2.77, P < .001) and Frailty Index (pooled HR = 1.74, 95% CI = 1.40-2.18, P < .001) to define frail people, whereas when using the diagnosis criteria of CSHA-CFS for frailty, the pooled HR was 2.82 (95% CI = 0.79-10.10, P = .111). In addition, the subgroup analysis for length of follow-up showed that studies with a follow-up period of 1 year or more (pooled HR = 1.83, 95% CI = 1.52, 2.21, P < .001) reported a significantly higher rate of mortality among individuals with frailty, compared to those without frailty. Similar results were also found in studies with a follow-up period of less than 1 year (pooled HR = 2.67, 95% CI = 1.43, 5.00, P = .002). CONCLUSIONS AND IMPLICATIONS: Frailty is a significant predictor of all-cause mortality in older nursing home residents. Therefore, there is an urgent need to screen for frailty in nursing home residents and carry out appropriate multidisciplinary intervention strategies to prevent poor outcomes and reduce the rate of mortality among older nursing home residents.
Copyright © 2018 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frailty; meta-analysis; mortality; nursing home residents; older people

Year:  2019        PMID: 30639171     DOI: 10.1016/j.jamda.2018.11.018

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  18 in total

1.  Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of Mortality.

Authors:  Breno S Diniz; Maria Fernanda Lima-Costa; Sérgio Viana Peixoto; Joselia O A Firmo; Karen C L Torres; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; James Grady; George A Kuchel; Erico Castro-Costa
Journal:  Am J Geriatr Psychiatry       Date:  2022-02-03       Impact factor: 7.996

2.  Social Support and Mortality in Community-Dwelling Chinese Older Adults: The Mediating Role of Frailty.

Authors:  Lijun Fan; Shiyuan Wang; Hui Xue; Yue Ding; Jingwen Wang; Yong Tian; Wei Du
Journal:  Risk Manag Healthc Policy       Date:  2021-04-16

3.  Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.

Authors:  John P Haran; Beth A McCormick
Journal:  Gastroenterology       Date:  2020-12-08       Impact factor: 22.682

4.  Frailty among Older Adults Living in Nursing Homes in Indonesia: Prevalence and Associated Factors.

Authors:  Aulia Rizka; Andika Indrarespati; Noto Dwimartutie; Muhadi Muhadi
Journal:  Ann Geriatr Med Res       Date:  2021-06-07

5.  Epigenetic age is associated with baseline and 3-year change in frailty in the Canadian Longitudinal Study on Aging.

Authors:  Chris P Verschoor; David T S Lin; Michael S Kobor; Oxana Mian; Jinhui Ma; Guillaume Pare; Gustavo Ybazeta
Journal:  Clin Epigenetics       Date:  2021-08-23       Impact factor: 6.551

6.  Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.

Authors:  Renly Lim; Luke Bereznicki; Megan Corlis; Lisa M Kalisch Ellett; Ai Choo Kang; Tracy Merlin; Gaynor Parfitt; Nicole L Pratt; Debra Rowett; Stacey Torode; Joseph Whitehouse; Andre Q Andrade; Rebecca Bilton; Justin Cousins; Lan Kelly; Camille Schubert; Mackenzie Williams; Elizabeth Ellen Roughead
Journal:  BMJ Open       Date:  2020-04-22       Impact factor: 2.692

Review 7.  A Methodological Quality Evaluation of Meta-Analyses on Nursing Home Research: Overview and Suggestions for Future Directions.

Authors:  In-Soo Shin; Juh-Hyun Shin; Dong-Eun Jang; Jiyeon Lee
Journal:  Int J Environ Res Public Health       Date:  2022-01-03       Impact factor: 3.390

Review 8.  Characteristics and Outcomes of Patients With Frailty Admitted to ICU With Coronavirus Disease 2019: An Individual Patient Data Meta-Analysis.

Authors:  Ashwin Subramaniam; Christopher Anstey; J Randall Curtis; Sushma Ashwin; Mallikarjuna Ponnapa Reddy; Márlon Juliano Romero Aliberti; Thiago Junqueira Avelino-Silva; Carly Welch; Gouri Koduri; John R Prowle; Yize I Wan; Michaël R Laurent; Alessandra Marengoni; Jun Pei Lim; David Pilcher; Kiran Shekar
Journal:  Crit Care Explor       Date:  2022-01-18

9.  Frailty Confers High Mortality Risk across Different Populations: Evidence from an Overview of Systematic Reviews and Meta-Analyses.

Authors:  Richard Ofori-Asenso; Ken Lee Chin; Berhe W Sahle; Mohsen Mazidi; Andrew R Zullo; Danny Liew
Journal:  Geriatrics (Basel)       Date:  2020-03-12

Review 10.  Cognitive frailty as a predictor of adverse outcomes among older adults: A systematic review and meta-analysis.

Authors:  ZiHan Bu; AnLe Huang; MengTing Xue; QingYun Li; YaMei Bai; GuiHua Xu
Journal:  Brain Behav       Date:  2020-11-06       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.